Header Logo

Connection

Godspower Akpomiemie to Imidazoles

Back to Details
This is a "connection" page, showing publications Godspower Akpomiemie has written about Imidazoles.
Godspower Akpomiemie
Connection Strength
0,053
Imidazoles
  1. Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. J Antimicrob Chemother. 2022 09 30; 77(10):2706-2712.
    View in: PubMed
    Score: 0,053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.